Cefiderocol-Based versus Colistin-Based Regimens for Severe Carbapenem-Resistant Acinetobacter baumannii Infections: A Propensity Score-Weighted, Retrospective Cohort Study during the First Two Years of the COVID-19 Pandemic

Background. A large increase in multi-drug-resistant Acinetobacter baumannii, especially carbapenem-resistant strains, occurred during the first two years of the COVID-19 pandemic, posing important challenges in its treatment. Cefiderocol appeared to be a good option for the treatment of Carbapenem-...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazzitelli, Maria, Gregori, Dario, Sasset, Lolita, Trevenzoli, Marco, Scaglione, Vincenzo, Lo Menzo, Sara, Marinello, Serena, Mengato, Daniele, Venturini, Francesca, Tiberio, Ivo, Navalesi, Paolo, Cattelan, Annamaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146662/
https://www.ncbi.nlm.nih.gov/pubmed/37110408
http://dx.doi.org/10.3390/microorganisms11040984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146662/
https://www.ncbi.nlm.nih.gov/pubmed/37110408
http://dx.doi.org/10.3390/microorganisms11040984

Ejemplares similares